Evidence map›Paper›PMID 38052216›Full record

ReviewCell chemical biology2024

Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.

Cydney N Johnson, Shyra Wilde, Elaine Tuomanen, Jason W Rosch

Abstract readReview
In one paragraph

Review in Cell chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Change in the distribution ofFrontiers in microbiology · 2026
    Article
  7. Article
  8. Review
  9. Global Antimicrobial Non-Susceptibility Patterns ofInfection and drug resistance · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Comparative analysis of theFrontiers in microbiology · 2025
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cydney N JohnsonDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Shyra WildeDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Elaine TuomanenDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: elaine.tuomanen@stjude.org.
Jason W RoschDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Funding

Drug resistance enablers and their role in antibiotic treatment failureU19AI158076 · NIAID · BROAD INSTITUTE, INC. · PI COOPER, VAUGHN, ISBERG, RALPH R. · 2022 to 2025
$10.0M
Bioactivities of pneumococcal cell wall in neuropathogenesisR01AI128756 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Elaine I Tuomanen · 2017 to 2026
$4.5M
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequencesR01AI171038 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Jason W. Rosch, Federico Antonio Rosconi · 2022 to 2026
$3.0M
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infectionR01AI172796 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Carlos J Orihuela, Min Xie · 2023 to 2026
$2.6M
Consequences of Direct Viral-Bacterial InteractionsR01AI168214 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Jason W. Rosch, Stacey L Schultz-Cherry · 2022 to 2026
$2.5M
Antibiotic tolerance: membraneless organelles and autolysin regulationR01AI165426 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Elaine I Tuomanen · 2022 to 2026
$2.3M
PspA binds necroptotic cells to cause disease and transmitR01AI156898 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ORIHUELA, CARLOS J · 2020 to 2024
$2.0M
NIAID NIH HHS R01 AI128756NIAID NIH HHS R01 AI156898NIAID NIH HHS R01 AI165426NIAID NIH HHS R01 AI168214NIAID NIH HHS R01 AI171038NIAID NIH HHS R01 AI172796NIAID NIH HHS U19 AI158076
6 · The paper itself

Abstract

Streptococcus pneumoniae is a remarkably adaptable and successful human pathogen, playing dual roles of both asymptomatic carriage in the nasopharynx and invasive disease including pneumonia, bacteremia, and meningitis. Efficacious vaccines and effective antibiotic therapies are critical to mitigating morbidity and mortality. However, clinical interventions can be rapidly circumvented by the pneumococcus by its inherent proclivity for genetic exchange. This leads to an underappreciated interplay between vaccine and antibiotic pressures on pneumococcal populations. Circulating populations have undergone dramatic shifts due to the introduction of capsule-based vaccines of increasing valency imparting strong selective pressures. These alterations in population structure have concurrent consequences on the frequency of antibiotic resistance profiles in the population. This review will discuss the interactions of these two selective forces. Understanding and forecasting the drivers of antibiotic resistance and capsule switching are of critical importance for public health, particularly for such a genetically promiscuous pathogen as S. pneumoniae.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsHumansPneumococcal VaccinesVaccinationVaccines, ConjugateAnti-Bacterial AgentsPneumococcal VaccinesVaccines, Conjugate

Identifiers

PMID38052216
PMCPMC10938186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.